Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Net Cash Flow (2016)

Microbot Medical's Net Cash Flow history spans 7 years, with the latest figure at $681546.0 for Q4 2016.

  • For the quarter ending Q4 2016, Net Cash Flow fell 80.13% year-over-year to $681546.0, compared with a TTM value of $8.1 million through Dec 2016, up 2381.96%, and an annual FY2025 reading of $810000.0, up 25.39% over the prior year.
  • Net Cash Flow for Q4 2016 was $681546.0 at Microbot Medical, down from $1.2 million in the prior quarter.
  • The five-year high for Net Cash Flow was $15.8 million in Q2 2015, with the low at -$10.8 million in Q1 2015.
  • Average Net Cash Flow over 5 years is $971735.6, with a median of -$275848.0 recorded in 2013.
  • Year-over-year, Net Cash Flow skyrocketed 982.98% in 2012 and then tumbled 234.3% in 2014.
  • Tracing MBOT's Net Cash Flow over 5 years: stood at -$7.2 million in 2012, then skyrocketed by 233.05% to $9.6 million in 2013, then crashed by 174.92% to -$7.2 million in 2014, then soared by 147.55% to $3.4 million in 2015, then plummeted by 80.13% to $681546.0 in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Net Cash Flow are $681546.0 (Q4 2016), $1.2 million (Q3 2016), and $687500.0 (Q2 2016).